Abstract
Purpose/Objective(s)To compare the rates of acute and late gastrointestinal (GI) and genitourinary (GU) toxicity associated with daily alignment to implanted fiducials via kV radiographs versus alignment to the prostate via cone-beam computed tomography (CBCT).Materials/MethodsTwo hundred twelve patients with clinically localized prostate cancer treated with hypofractionated prostate radiation therapy (RT) between 2005 and 2011 were included in this analysis. All patients received 70 Gy to the prostate in 28 fractions and 103 patients received simultaneous 50.4 Gy to the pelvic lymph nodes. Daily image-guided alignment was performed either to implanted fiducial markers with kV radiographs or to the prostate or prostate-rectum interface via CBCT. Acute and late GI and GU toxicity were retrospectively scored by the CTCAE 4.0 scale and statistical analysis was performed using IBM SPSS version 22 software.ResultsScientific Abstract 2589; TableProstate-only (n = 109)Fiducials (n = 23)CBCT (n = 86)PAcute GI217.214Acute GU1141.990Late GI32.020Late GU26.650Lymph Nodes treated (n = 103)Fiducials (n = 19)CBCT (n = 84)PAcute GI731.996Acute GU1341.122Late GI113.383Late GU17.842 Open table in a new tab ConclusionsThe acute GU and GI toxicities are similar in patients receiving fiducial-based or CBCT alignment. For patients receiving prostate-only RT, the rate of late GI toxicity was increased for patients with implanted fiducials. Late GU toxicity was not increased for patients receiving fiducial-based alignment despite the inability to evaluate daily bladder filling in this group. Purpose/Objective(s)To compare the rates of acute and late gastrointestinal (GI) and genitourinary (GU) toxicity associated with daily alignment to implanted fiducials via kV radiographs versus alignment to the prostate via cone-beam computed tomography (CBCT). To compare the rates of acute and late gastrointestinal (GI) and genitourinary (GU) toxicity associated with daily alignment to implanted fiducials via kV radiographs versus alignment to the prostate via cone-beam computed tomography (CBCT). Materials/MethodsTwo hundred twelve patients with clinically localized prostate cancer treated with hypofractionated prostate radiation therapy (RT) between 2005 and 2011 were included in this analysis. All patients received 70 Gy to the prostate in 28 fractions and 103 patients received simultaneous 50.4 Gy to the pelvic lymph nodes. Daily image-guided alignment was performed either to implanted fiducial markers with kV radiographs or to the prostate or prostate-rectum interface via CBCT. Acute and late GI and GU toxicity were retrospectively scored by the CTCAE 4.0 scale and statistical analysis was performed using IBM SPSS version 22 software. Two hundred twelve patients with clinically localized prostate cancer treated with hypofractionated prostate radiation therapy (RT) between 2005 and 2011 were included in this analysis. All patients received 70 Gy to the prostate in 28 fractions and 103 patients received simultaneous 50.4 Gy to the pelvic lymph nodes. Daily image-guided alignment was performed either to implanted fiducial markers with kV radiographs or to the prostate or prostate-rectum interface via CBCT. Acute and late GI and GU toxicity were retrospectively scored by the CTCAE 4.0 scale and statistical analysis was performed using IBM SPSS version 22 software. ResultsScientific Abstract 2589; TableProstate-only (n = 109)Fiducials (n = 23)CBCT (n = 86)PAcute GI217.214Acute GU1141.990Late GI32.020Late GU26.650Lymph Nodes treated (n = 103)Fiducials (n = 19)CBCT (n = 84)PAcute GI731.996Acute GU1341.122Late GI113.383Late GU17.842 Open table in a new tab ConclusionsThe acute GU and GI toxicities are similar in patients receiving fiducial-based or CBCT alignment. For patients receiving prostate-only RT, the rate of late GI toxicity was increased for patients with implanted fiducials. Late GU toxicity was not increased for patients receiving fiducial-based alignment despite the inability to evaluate daily bladder filling in this group. The acute GU and GI toxicities are similar in patients receiving fiducial-based or CBCT alignment. For patients receiving prostate-only RT, the rate of late GI toxicity was increased for patients with implanted fiducials. Late GU toxicity was not increased for patients receiving fiducial-based alignment despite the inability to evaluate daily bladder filling in this group.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.